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Abstract
At present, data on the endocannabinoid
system expression and distribution in the
pancreatic gland appear scarce and contro-
versial as descriptions are limited to
humans and laboratory animals. Since the
bovine pancreas is very similar to the
human in endocrine portion development
and control, studies on the fetal gland could
prove to be very interesting, as an abnormal
maternal condition during late pregnancy
may be a predisposing trigger for adult
metabolic disorders. The present investiga-
tion studied cannabinoid receptor type 2
presence and distribution in the bovine fetal
pancreas towards the end of gestation.
Histological analyses revealed numerous
endocrinal cell clusters or islets which were
distributed among exocrine adenomeri in
connectival tissue. Immunohistochemistry
showed that endocrine-islets contained
some CB2-positive cells with a very pecu-
liar localization that is a few primarily
localized at the edges of islets and some of
them also scattered in the center of the clus-
ter. Characteristically, also the epithelium of
the excretory ducts and the smooth muscle
layers of the smaller arteries, in the interlob-
ular glandular septa, tested positive for the
CB2 endocannabinoid receptor. Conse -
quently, the endocannabinoid system, via
the cannabinoid receptor type 2, was
hypothesized to play a major role in con-
trolling pancreas function from normal fetal
development to correct metabolic function-
ing in adulthood.
Introduction
The ‘endogenous cannabinoid system’,
which connects the gastrointestinal appara-
tus and the hypothalamus, plays a role in
controlling several physiological functions
of central and peripheral organs. As a com-
plex molecular system, it includes several
lipidic molecules or endo-cannabinoids that
bind to specific receptors (CB1 and CB2) as
well as the many enzymes that are involved
in cannabinoid biosynthesis and inactiva-
tion. 
The CB2 cannabinoid receptor is much
less common in the body than CB1 but it is
certainly expressed in the immune system,
hematopoietic cells and even, according to
recent studies, in some brain regions1 and
other peripheral organs and tissues.2-5
In particular, in male and female adults,
CB2 receptors were detected in the
endocrine pancreas of humans and laborato-
ry animals,3,6 thus providing further evi-
dence to support the importance of the
cannabinoid system in regulating the energy
balance, given the endocrine role of the
pancreas in insulin and glucagon incretion,
control of serum glucose concentrations7
and consequent cell utilization. Moreover, a
recent study evidenced the importance of
endocannabinoids in the control of cell pro-
liferation and organization, with a particular
look to the fetal pancreas development.8
However, the expression of the components
of the endocannabinoid system in the pan-
creas still needs to be elucidated because
often there is no consensus on its distribu-
tion in the endocrine islets, for which
descriptions are starkly contrasting, espe-
cially between animals of different species,
such as rats and mice.9,10 Moreover, in
human pancreas the CB2 receptor was also
found in the exocrine pancreas, unlike what
had been previously reported for laboratory
animals.6,11
Since no data are available on CB2
receptor distribution in the pancreas of pet
animals and livestock, the present investiga-
tion was designed to fill this gap and to con-
tribute to clear up the discrepancies high-
lighted by many reports in the literature. In
opening this new field of investigation in
domestic animals, we decided to start by
mapping the distribution of CB2 receptors
in the pancreas of bovine fetuses as this
species is expected to be closer to humans
than laboratory animals in the development
of different types of endocrine cells12 and in
the mechanisms controlling  pancreatic
development.13 The decision to focus on the
pancreas of  fetuses derived from the con-
cept of ‘fetal programming’, which encom-
passes not only environmental, but also
maternal influences.  The maternal metabol-
ic status exposes the fetus to complex fac-
tors that condition gene expression (epige-
netics) and fetal metabolism overall, partic-
ularly in the late stage of gestation. In fact,
the so-called ‘transition period’, which
identifies the late pregnancy and the early
lactation in cows, is a critical time in the
management of both  cow and  calf14 as,
unless correct, it can affect the offspring,
with the risk of congenital diseases appear-
ing in adulthood.15
Materials and Methods
After emergency slaughter, 5 bovine
fetuses at the 8th month of gestation, were
collected and examined. All procedures
were carried out following Italian legisla-
tion on animal care (DL n.116, 21/01/1992).
Each pregnant uterus was immediately
transported to the necropsy room at the
Department of Veterinary Medicine. Each
fetus was dissected and pancreas samples
were immediately fixed by immersion in a
4% formaldehyde solution, to be subse-
quently processed for embedding in paraf-
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fin wax. To assess morphometry some sec-
tions were processed by hematoxylin-eosin
staining. The immunohistochemical sites
were visualized using the following
reagents: normal goat serum (1:10, sc-2043;
Santa Cruz Biotechnology, Santa Cruz, CA,
USA), anti-CB2 rabbit polyclonal antibody
(1:100, sc-25494; Santa Cruz
Biotechnology), biotinylated goat anti-rab-
bit IgG (1:200, AP132B; Chemicon,
Temecula, CA, USA), avidin-biotin-com-
plex (ABC KIT, PK-6100, Vector Lab., Inc.,
Burlingame, CA, USA) and diaminobenzi-
dine (DAB, SK-4100, Vector Lab., Inc.) as
the chromogen. The primary antibody sc-
25494, anti-CB2, was recommended for
bovine tissues by the manufacturer, show-
ing a high percentage of homology (around
85%) between human and bovine, and was
already used in a study using bovine tis-
sue.16
Briefly, dewaxed sections were
microwaved for 15 min in 10 mM citric acid
for antigen retrieval and, after proper cool-
ing, were incubated with normal serum for
30 min. The following step concerned the
incubation overnight with the primary anti-
body. The next day, after washing in PBS,
sections were incubated with the secondary
biotin-conjugated antibody for 30 min and
subsequently, for other 30 min, with the
ABC kit. The reaction was visualized using
the chromogen solution and then sections
were dehydrated and mounted in natural
Canada balsam (BDH, Poole, UK). On seri-
al sections, a morphometric analysis was
conducted to better border the endocrine
area and so identify the CB2-positive cells
as endocrine-cells. 
Sections with PBS instead of primary
antibodies were used as controls of unspe-
cific staining. Sections of bovine spleen
were used as a positive control for CB2
antibody. To score the immunohistochemi-
cal results, the endocrine cells were consid-
ered positive for CB2 only when cytoplas-
mic staining was evident, independently of
its immunointensity. In order to determine
the CB2-labelling index, the percentage of
positive CB2 cells for each fetus was deter-
mined. All tissue analyses were carried out
on coded slides using a light microscope
(Nikon Eclipse E800) connected to a digital
camera (Dxm 1200 Nikon digital camera). 
Results
Hematoxylin-eosin stained tissues
revealed many ovoid or round endocrine
cell clusters, scattered throughout the
exocrine parenchyma (Figure 1, asterisks).
Single endocrine cells were occasionally
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Figure 1. Light microphotograph of the pancreas of bovine fetus at the 8th month of ges-
tation: many ovoid or round endocrine cell clusters are evident (asterisks) throughout
the exocrine parenchyma.
Figure 2. Serial sections that identify the endocrine portion (arrows-head) and the pres-
ence of some isolated cells (arrow), where it is possible to observe the immunopositivity
for CB2. a) CB2 immunopositivity. b) Hematoxylin-eosin.
Figure 3. CB2 immunohistochemistry in the pancreas of bovine fetuses.
Immunopositivity is localized in the cytoplasm of some endocrine cells (a), mainly at the
edge of the endocrine islands (arrows). b) CB2 immunopositivity also localized in the
muscular layer of the connective arteries. The inserts are examples of immunohistochem-
ical sections negative for CB2 in which the primary antibody was omitted.
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observed scattered throughout the exocrine
gland (Figure 2 a,b, arrows). Positive
immunoreaction (IR) for CB2 (Figures 2a
and 3) was found in the cytoplasm of the
endocrine cells. In particular, in the
endocrine clusters, some of the endocrine
cells on the edges of the clusters (Figure 3a,
arrows), were cytoplasmic CB2+ as well as
some of them were also scattered in the cen-
ter of the cluster.  Overall, the immunopos-
itivity for CB2 was observed in 4-10% of
endocrine cells. Moreover, positive staining
for CB2 was observed in the muscle layer
cells of the small arteries supplying the pan-
creatic parenchyma (Figure 3b) and in some
control sections of bovine spleen (Figure 4).
Occasionally, a positive CB2 immunoreac-
tion was also observed in the epithelial cells
of ducts (Figure 5, arrow). Staining was
completely absent in the control sections,
using PBS (insert in Figure 3). 
Discussion
The pancreas is a complex gland. Its
exocrine portion produces digestive
enzymes and active peptides for the luminal
content of duodenum (pancreatic juice),
while its endocrine portion produces and
incretes particular hormones into the blood-
stream, some of which control circulating
glucose concentrations in serum and glu-
cose utilization by cells. 
During embryogenesis, pancreatic
development starts from ventral and dorsal
portions of the endoderm which, despite
being initially separated, follow the stom-
ach and duodenum rotation, and then merge
to form one single organ. Although the two
secreting portions of the pancreas develop
in diverse phases in the different species,
the endocrine portion generally precedes
the exocrine and is controlled by a complex
sequence of actions of transcription
factors.17
As far as we know, this is the first report
describing CB2 receptor expression and
localization in the pancreas of domestic ani-
mals, notably bovine fetuses.
Immunohistochemistry showed a very
peculiar distribution of CB2 receptor in
fetal endocrine islets. CB2+ cells were
detected on the edges of clusters and scat-
tered without a precise location in the center
of islets. Interestingly, the CB2 receptor
was found in the epithelial cells of excreto-
ry ducts and in the smooth muscle cells of
the arteries within the interlobular pancreat-
ic connective septa, concurring with obser-
vations in laboratory animals.6,18
Although CB2 receptor is described as
membrane receptor and is effectively a
transmembrane protein, it is common, as
demonstrated in this study, to see immuno-
histochemical reactions in cytoplasm. As
already stated19,20 for CB1 receptor, this kind
of receptor protein shuttles permanently
between plasma membrane and cytoplasm
with, very often, a predominantly intracel-
lular localization.
In conclusion, given the distribution
patterns we detected, we hypothesize that
the cannabinoid molecules are implicated in
control of gland functioning as already
observed and demonstrated in laboratory
animals,8 probably by acting on some
endocrine cells, epithelial excretory ducts
and on small arterial vessel walls as the
cannabinoid CB2 receptor was detected in
these sites. 
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Figure 4. CB2-immunopositivity in the bovine spleen: positive control.
Figure 5. CB2-immunpositivity in the epithelial cells of the exocrine ducts.
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